Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
2020; Elsevier BV; Volume: 395; Issue: 10236 Linguagem: Inglês
10.1016/s0140-6736(20)31022-9
ISSN1474-547X
AutoresYeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Qiaofa Lu, Yi Hu, Guangwei Luo, Ke Wang, Yang Lü, Huadong Li, Shuzhen Wang, Shunan Ruan, Haijun Yang, Chunlin Mei, Yi Wang, Dan Ding, Feng Wu, Xin Tang, Xianzhi Ye, Yingchun Ye, Bing Liu, Jie Yang, Wen Yin, Aili Wang, Guohui Fan, Fei Zhou, Zhibo Liu, Xiaoying Gu, Jiuyang Xu, Lianhan Shang, Yi Zhang, Lianjun Cao, Tingting Guo, Yan Wan, Hong Qin, Yushen Jiang, Thomas Jaki, Frederick G. Hayden, Peter Horby, Bin Cao, Chen Wang,
Tópico(s)SARS-CoV-2 and COVID-19 Research
Referência(s)